Systematic Biopsies as a Complement to Magnetic Resonance Imaging-targeted Biopsies: "To Be or Not To Be"?
Journal
European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
04
01
2023
accepted:
11
01
2023
medline:
18
4
2023
pubmed:
4
2
2023
entrez:
3
2
2023
Statut:
ppublish
Résumé
In light of recent prostate cancer screening programme proposed by the European Association of Urology, there is an urgent need to optimise detection of clinically significant cancer while minimising overdiagnosis. This may be achieved by omitting systematic biopsies while ensuring quality control for diagnostic magnetic resonance imaging and targeted biopsies.
Identifiants
pubmed: 36737297
pii: S0302-2838(23)00019-2
doi: 10.1016/j.eururo.2023.01.012
pii:
doi:
Substances chimiques
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Editorial
Langues
eng
Sous-ensembles de citation
IM
Pagination
381-384Informations de copyright
Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.